title: The genomic map of breast cancer: which roads lead to better targeted therapies?
abstract: Recent advances in whole-genome technologies have supplied the field of cancer research with an overwhelming amount of molecular data. Improvements in massively parallel sequencing approaches have led to logarithmic decreases in costs, and so these methods are becoming almost commonplace in the analysis of clinical trials and other cohorts of interest. Furthermore, whole-transcriptome quantification by RNA sequencing is quickly replacing microarrays. However, older chip-based methodologies such as comparative genomic hybridization and single-nucleotide polymorphism arrays have benefited from this technological explosion and are now so accessible that they can be employed in increasingly larger cohorts of patients. The study of breast cancer lends itself particularly well to these technologies. It is the most commonly diagnosed neoplasm in women, giving rise to nearly 230,000 new cases each year. Many patients are given a diagnosis of early-stage disease, for which surgery is the standard of care. These attributes result in excellent availability of tissues for whole-genome/transcriptome analysis. The Cancer Genome Atlas project has generated comprehensive catalogs of publically available genomic breast cancer data. In addition, other studies employing the power of genomic technologies in medium to large cohorts were recently published. These data are now publically available for the generation of novel hypotheses. However, these studies differed in the methods, patient cohorts, and analytical techniques employed and represent complementary snapshots of the molecular underpinnings of breast cancer. Here, we will discuss the convergences and divergences of these reports as well as the scientific and clinical implications of their findings.
authors.forename: Justin M
authors.initials: JM
authors.lastname: Balko
authors.forename: Thomas P
authors.initials: TP
authors.lastname: Stricker
authors.forename: Carlos L
authors.initials: CL
authors.lastname: Arteaga
mesh_terms: D000818:Animals; D001943:Breast Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy; D002986:Clinical Trials as Topic; D005260:Female; D020869:Gene Expression Profiling; D023281:Genomics; D006801:Humans; D058990:Molecular Targeted Therapy
references.citation: Nature. 2012 May 16;486(7403):400-4
references.pmid: 22722201
references.citation: Clin Cancer Res. 2010 May 1;16(9):2634-45
references.pmid: 20406831
references.citation: Science. 2013 Feb 1;339(6119):543-8
references.pmid: 23239622
references.citation: Cancer Res. 1989 Jun 1;49(11):3104-8
references.pmid: 2566377
references.citation: Nat Genet. 1997 Jul;16(3):311-5
references.pmid: 9207801
references.citation: J Clin Oncol. 2009 Mar 10;27(8):1160-7
references.pmid: 19204204
references.citation: Breast Cancer Res Treat. 2011 Jul;128(1):155-63
references.pmid: 21499685
references.citation: Breast Cancer Res Treat. 2009 May;115(2):359-63
references.pmid: 18649131
references.citation: J Thorac Oncol. 2012 Oct;7(10):e23-4
references.pmid: 22743296
references.citation: Lancet Oncol. 2011 Oct;12(11):1004-12
references.pmid: 21933749
references.citation: N Engl J Med. 2004 Dec 30;351(27):2817-26
references.pmid: 15591335
references.citation: Anticancer Drugs. 2012 Sep;23(8):765-76
references.pmid: 22824822
references.citation: Cancer Res. 1998 Jun 1;58(11):2339-42
references.pmid: 9622070
references.citation: Oncologist. 2010;15 Suppl 5:39-48
references.pmid: 21138954
references.citation: Cancer Res. 2009 Jan 15;69(2):565-72
references.pmid: 19147570
references.citation: N Engl J Med. 2013 Mar 28;368(13):1199-209
references.pmid: 23484797
references.citation: Lung Cancer. 2012 Jan;75(1):66-72
references.pmid: 21757253
references.citation: Lancet. 2010 Jul 24;376(9737):235-44
references.pmid: 20609467
references.citation: Bioinformatics. 2010 Jun 15;26(12):i237-45
references.pmid: 20529912
references.citation: Cell. 2012 May 25;149(5):979-93
references.pmid: 22608084
references.citation: Breast Cancer Res. 2010;12(4):207
references.pmid: 20804570
references.citation: Endocr Relat Cancer. 2010 Sep 23;17(4):R245-62
references.pmid: 20647302
references.citation: Cancer Discov. 2013 Feb;3(2):224-37
references.pmid: 23220880
references.citation: N Engl J Med. 2009 Jul 9;361(2):123-34
references.pmid: 19553641
references.citation: Thorax. 2006 Jan;61(1):91
references.pmid: 16396957
references.citation: N Engl J Med. 2012 Mar 8;366(10):883-892
references.pmid: 22397650
references.citation: CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29
references.pmid: 22237781
references.citation: Nature. 2012 Oct 4;490(7418):61-70
references.pmid: 23000897
references.citation: Curr Opin Genet Dev. 2010 Jun;20(3):201-9
references.pmid: 20418093
references.citation: Nature. 2010 Apr 15;464(7291):999-1005
references.pmid: 20393555
references.citation: Nature. 2000 Aug 17;406(6797):747-52
references.pmid: 10963602
references.citation: Breast Cancer Res. 2010;12(5):R68
references.pmid: 20813035
references.citation: Sci Transl Med. 2012 Mar 28;4(127):127rv2
references.pmid: 22461643
references.citation: Oncogene. 1992 Feb;7(2):355-61
references.pmid: 1532244
references.citation: Nature. 2012 Jun 20;486(7403):405-9
references.pmid: 22722202
references.citation: J Natl Cancer Inst. 2009 May 20;101(10):736-50
references.pmid: 19436038
references.citation: J Natl Cancer Inst. 2007 Jan 17;99(2):167-70
references.pmid: 17228000
references.citation: Breast Cancer Res Treat. 2010 May;121(1):53-64
references.pmid: 19593635
references.citation: J Pathol. 2012 May;227(1):42-52
references.pmid: 22252965
references.citation: Breast Cancer Res Treat. 2007;105 Suppl 1:33-43
references.pmid: 17912634
references.citation: J Exp Med. 2012 Apr 9;209(4):679-96
references.pmid: 22430491
references.citation: J Clin Oncol. 2007 Apr 1;25(10):1239-46
references.pmid: 17401012
references.citation: Science. 2012 Oct 12;338(6104):221
references.pmid: 22923433
references.citation: Nature. 2011 Apr 7;472(7341):90-4
references.pmid: 21399628
references.citation: Cancer. 2010 Mar 15;116(6):1431-9
references.pmid: 20131351
references.citation: Nature. 2012 Apr 04;486(7403):395-9
references.pmid: 22495314
references.citation: Nature. 2012 Jun 10;486(7403):353-60
references.pmid: 22722193
references.citation: Nat Genet. 2012 Jan 22;44(3):312-8
references.pmid: 22267197
references.citation: Cell. 2012 May 25;149(5):994-1007
references.pmid: 22608083
references.citation: N Engl J Med. 2010 Oct 28;363(18):1693-703
references.pmid: 20979469
references.citation: Genome Biol. 2007;8(5):R76
references.pmid: 17493263
references.citation: J Clin Oncol. 2008 Mar 10;26(8):1275-81
references.pmid: 18250347
references.citation: J Clin Invest. 2011 Jul;121(7):2750-67
references.pmid: 21633166
references.citation: Nature. 2012 Apr 18;486(7403):346-52
references.pmid: 22522925